Log in

600211 Tibet Rhodiola Pharmaceutical Holding Co. SSE · China

Tibet Rhodiola Pharmaceutical Holding Co. (600211) news

Tibet Rhodiola Pharmaceutical Holding Co. is a public biotech or pharmaceutical company listed on SSE under the ticker 600211, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Tibet Rhodiola Pharmaceutical Holding Co. news

We have not published a story on Tibet Rhodiola Pharmaceutical Holding Co. yet. When there is news, it will appear here.

Questions about Tibet Rhodiola Pharmaceutical Holding Co.

What is the ticker symbol of Tibet Rhodiola Pharmaceutical Holding Co.?

Tibet Rhodiola Pharmaceutical Holding Co. trades under the ticker 600211 on SSE.

Where is Tibet Rhodiola Pharmaceutical Holding Co. listed?

Tibet Rhodiola Pharmaceutical Holding Co. is listed on SSE.

Which country or territory is Tibet Rhodiola Pharmaceutical Holding Co. listed under?

Our directory records Tibet Rhodiola Pharmaceutical Holding Co. under China.

What does Tibet Rhodiola Pharmaceutical Holding Co. do?

Our directory classifies Tibet Rhodiola Pharmaceutical Holding Co. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Tibet Rhodiola Pharmaceutical Holding Co.?

The ISIN recorded for Tibet Rhodiola Pharmaceutical Holding Co. is CNE000000ZW7.

Does aibio.space cover Tibet Rhodiola Pharmaceutical Holding Co.?

aibio.space lists Tibet Rhodiola Pharmaceutical Holding Co. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Tibet Rhodiola Pharmaceutical Holding Co.?

Companies in our directory listed in the same country and business area as Tibet Rhodiola Pharmaceutical Holding Co.: Yantai Dongcheng Biochemicals Co., Shandong Jincheng Pharmaceutical Group Co., Cachet Pharmaceutical Co., Guizhou Xinbang Pharmaceutical Co., Clover Biopharmaceuticals, Shanghai Pharmaceuticals Holding Co..

Investor discussion: Tibet Rhodiola Pharmaceutical Holding Co.

Members talk about Tibet Rhodiola Pharmaceutical Holding Co. (600211). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:600211 on TradingView.

Listing details

Tibet Rhodiola Pharmaceutical Holding Co. is a public biotech or pharmaceutical company listed on SSE under the ticker 600211, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Tibet Rhodiola Pharmaceutical Holding Co.
Ticker
600211
Listing
SSE
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
CNE000000ZW7
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.